SKI Market

Indian Indices

Sensex

83,580.40 266.47
( 0.32%)

Global Indices

Nasdaq

48,934.28 -588.03
(-1.19%)

Dow Jones

6,820.12 -83.60
(-1.21%)

Hang Seng

54,176.23 358.19
(0.67%)

Nikkei 225

10,300.09 -102.25
(-0.98%)

Forex

USD-INR

90.39 0.07
(0.07%)

EUR-INR

106.79 0.14
(0.13%)

GBP-INR

123.73 0.13
(0.10%)

JPY-INR

0.58 0.00
(-0.49%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Procter & Gamble Health Ltd

Industry : Pharmaceuticals - Multinational

BSE Code

ISIN Demat

Book Value()

500126

INE199A01012

373.3448522

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

PGHL

28.45

8729.45

EPS(TTM)

Face Value()

Div & Yield %

184.83

2.38

Back

Procter & Gamble Health standalone net profit rises 7.54% in the September 2025 quarter

Nov 05,2025

Net profit of Procter & Gamble Health rose 7.54% to Rs 88.54 crore in the quarter ended September 2025 as against Rs 82.33 crore during the previous quarter ended September 2024. Sales rose 3.67% to Rs 324.92 crore in the quarter ended September 2025 as against Rs 313.41 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	324.92	313.41	4
OPM %	37.02	36.39	-
PBDT	125.10	117.17	7
PBT	119.02	111.40	7
NP	88.54	82.33	8

83,580.40 266.47 ( 0.32%)

48,934.28 -588.03 (-1.19%)

6,820.12 -83.60 (-1.21%)

54,176.23 358.19 (0.67%)

10,300.09 -102.25 (-0.98%)

90.39 0.07 (0.07%)

106.79 0.14 (0.13%)

123.73 0.13 (0.10%)

0.58 0.00 (-0.49%)